36.42
36.42 (0%)
As of Feb 14, 2025
Legend Biotech Corp [LEGN]
Source:
Company Overview
Legend Biotech Corp is a global biopharmaceutical company engaged in the discovery, development, manufacturing and commercialization of novel cell therapies for oncology and other indications.
| Country | Cayman Islands |
| Headquarters | somerset, new jersey |
| Phone Number | (737) 317-5050 |
| Industry | manufacturing |
| CEO | Ying Huang |
| Website | www.legendbiotech.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $627.2 |
| Operating Profit | |
| Net Income | $-177 |
| Net Cash | $-988.9 |
Profit Ratios
| Gross Margin | $861.8 |
| Operating Margin | |
| Profit as % of Revenues | -486.8% |
| Profit as % of Assets | -10.1% |
| Profit as % of Stockholder Equity | -17% |
Management Effectiveness
| Return on Equity | -17% |
| Return on Assets | -10.6% |
| Turnover Ratio | 35.7% |
| EBITA |
Balance Sheet and Cash Flow Measures
| Total Assets | $1,670.2 |
| Total Liabilities | $629.6 |
| Operating Cash Flow | $-144 |
| Investing Cash Flow | $-850.5 |
| Financing Cash Flow | $5.7 |
